Oculus Innovative plans to price public offering of equity units

Funds to be used to increase direct sales force, launch new products

By Toni Weeks

San Luis Obispo, Calif., Nov. 21 – Oculus Innovative Sciences, Inc. said it plans to price a public sale of units with a 45-day greenshoe option, according to an8-K filing with the Securities and Exchange Commission.

The company will sell units of one common share and one five-year warrant.

Maxim Group, LLC is the bookrunner.

The company said it intends to apply for listing of the warrants on the Nasdaq Capital Market.

Proceeds will be used to increase the company’s direct sales force, to develop and launch new products and for general working capital.

Oculus is a specialty pharmaceutical company based in Petaluma, Calif., that develops and markets solutions for the treatment of dermatological conditions and tissue care.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.